Answer Capsule
Pacific Life is a mixed fit for an otherwise stable adult with Type 2 diabetes. Four of the seven platforms in this study named Pacific Life during the ranking stage — 57% of included platform responses — at an average listed rank of 5.5 and a best listed rank of 4. The strongest reason to consider it is Pacific Elite Term and PL Promise Term, which offer level-premium term coverage, conversion flexibility, and accelerated underwriting pathways. The main limitation is that Pacific Life does not publicly disclose diabetes-specific underwriting thresholds, rate classes, or sample premiums, so no platform could confirm it as the best carrier for this condition without a case-specific quote.
Research Snapshot
| Field | Finding |
|---|---|
| Platform mentions in ranking stage | 4 of 7 platforms (anthropic, deepseek, kimi, perplexity) |
| Share of included platform responses | 57.1% |
| Average listed rank | 5.5 |
| Best listed rank | 4 (deepseek) |
| Relevant product/model/plan | Pacific Elite Term; PL Promise Term where available; PL Promise GUL for lifetime no-lapse coverage |
| Overall use-case fit | Mixed |
| Research date | 2026-09-22 |
Why Pacific Life Qualified for This Study
Questions This Section Answers
- Is Pacific Life a good choice for life insurance for Type 2 diabetes?
- Why did only four of seven AI platforms rank Pacific Life for Type 2 diabetes applicants?
Pacific Life qualified because four of the seven platforms named it as a carrier worth considering for an adult with Type 2 diabetes, clearing the study's two-mention threshold. Its qualifying products were term and permanent life insurance with individualized medical underwriting rather than automatic decline for diabetes [1].
The four platforms that named it ranked it between fourth and seventh. Deepseek placed it highest at fourth; kimi fifth; anthropic sixth; perplexity seventh. Three platforms — google, grok, and openai — evaluated Pacific Life's fit but did not name it in their ranking-stage carrier lists, so their fit findings still appear in this review even though they do not count toward the mention total.
Pacific Life's public materials describe term and permanent products, underwriting review, and financial-strength ratings [3]. No platform supplied evidence that Pacific Life operates a diabetes-specific underwriting program, and none claimed it is the single best carrier for this condition.
The Product, Model, Plan, or Service Most Relevant to Life Insurance for Type 2 Diabetes
Questions This Section Answers
- Which Pacific Life plan should a buyer with Type 2 diabetes choose for term coverage versus lifetime coverage?
- Is Pacific Elite Term or PL Promise Term the better Pacific Life option for a Type 2 diabetes applicant?
Pacific Elite Term is the clearest relevant product for this use case, with PL Promise Term as a secondary term option and PL Promise GUL as the permanent alternative. Pacific Elite Term provides level-premium coverage for 10-, 20-, or 30-year periods, generally with face amounts beginning at $250,000, and may be converted to eligible Pacific Life cash-value coverage without additional underwriting during the stated conversion period [5].
PL Promise Term is described with 10-, 15-, 20-, 25-, and 30-year terms, a $50,000 minimum, and conversion without new underwriting through insured age 70 [8]. One official page labels PL Promise Term as California-only, while other materials describe broader availability, so current state-specific availability is uncertain [5].
PL Promise GUL is identified by Pacific Life as no-lapse-guarantee universal life with a level-premium design and chronic-illness and terminal-illness living-benefit style riders [9]. It is more relevant than term when the objective is coverage intended to last for life, but it is a more complex permanent product.
Product naming is inconsistent across platforms. Ranking-stage responses referenced Pacific Elite Term, Promise GUL, Promise Term, and Premier Term, while the currently reviewed official term page identifies Pacific Elite Term and PL Promise Term [5]. Buyers should verify which product is actually being quoted.
What the AI Platforms Agreed About
Questions This Section Answers
- What do AI platforms agree on about Pacific Life for Type 2 diabetes life insurance?
- Does Pacific Life publicly publish diabetes-specific underwriting criteria or rates?
Platforms broadly agreed on four points. First, Pacific Life uses individualized medical underwriting rather than categorical exclusion, so Type 2 diabetes is evaluated as part of the application [12]. Second, Pacific Life does not publicly publish Type 2 diabetes-specific underwriting guidelines, A1C thresholds, insulin rules, or rate tables [14].
Third, Pacific Life's financial-strength ratings are a positive carrier-selection factor. Its 2026 materials list AA- from S&P and Fitch, Aa3 from Moody's, and A+ from A.M. Best, with the caveat that ratings are opinions about financial obligations, not product recommendations [16].
Fourth, term coverage is convertible. Multiple platforms described conversion to eligible permanent coverage without new medical underwriting, subject to product, state, and timing rules [18].
Agreement on these four points was strong across the platforms that addressed them. Agreement does not establish product quality or favorable diabetes underwriting.
Where the AI Platforms Disagreed or Were Uncertain
Questions This Section Answers
- Do AI platforms disagree about whether Pacific Life is a good fit for Type 2 diabetes?
- What is unverified about Pacific Life's Type 2 diabetes underwriting and pricing?
Fit ratings split. Anthropic, google, grok, kimi, and perplexity rated Pacific Life a good fit; openai and deepseek rated it mixed. The disagreement centers on how much weight to give broker-reported underwriting guidelines that Pacific Life itself does not publish.
Underwriting detail is the largest uncertainty. One underwriting guide found through an intermediary source states that standard may be available for Type 2 diabetes diagnosed after age 50 with optimal control and no complications [21]. Kimi reported that Pacific Life can offer Standard Plus Non-Tobacco rates for applicants diagnosed after age 50 with A1C under 7.0 and otherwise optimal health metrics [23]. Google reported Standard Non-Tobacco rates for post-50 diagnosis with HbA1c under 7.0 and no complications [24]. These are broker and third-party summaries, not Pacific Life-published thresholds, and the exact A1C cutoff for standard versus table ratings is not precisely delineated.
Platforms also disagreed on competitive position. Kimi and google described Pacific Life as a secondary option behind Banner Life for well-controlled diabetes, while grok described it as accommodating for A1C in the 7.0–7.5 band [23]. No platform supplied Pacific Life's internal approval rate, average assigned rating, or percentage of Type 2 applicants approved versus declined.
Pricing for table-rated diabetics is unpublished. Pacific Life's public rate comparisons show only standard and preferred non-tobacco classes, with no publicly available pricing for applicants rated Table 4 or higher [26]. One platform reported a substandard structure of +20% per table step versus a traditional +25%, but this is platform-reported and should be verified [28].
Use-Case-Specific Features and Capabilities
Questions This Section Answers
- What underwriting pathways does Pacific Life offer a Type 2 diabetes applicant who wants to avoid a medical exam?
- How does Pacific Life's conversion feature help a Type 2 diabetes buyer whose health changes?
Pacific Life's most relevant capabilities for this use case are accelerated underwriting pathways, conversion rights, living-benefit riders, and comparatively generous build guidelines.
Pacific Accelerated Life+ (PAL+) is described with three pathways: accelerated (no exam or attending physician statement, ages 18–60, up to $3M for PL Promise Term, standard-or-better risk class only), modified (labs within 12 months, ages 18–70), and traditional (all ages and amounts) [29]. Perplexity reported no-exam accelerated underwriting for PL Promise Term up to $3M for ages 18–60, a physical-with-labs path for PL Promise Term up to $3M for ages 18–70, and physical-with-labs underwriting for PL Promise GUL up to $2M for ages 18–70 [30].
Accelerated underwriting does not guarantee an exam-free or approved outcome. The NAIC notes that life insurers may use application data, external data, analytics, and sometimes physical exams or fluid testing depending on the case [32]. Multiple platforms concluded that most Type 2 diabetics will be routed to the modified pathway with an attending physician statement and recent labs rather than the no-exam pathway [33].
Conversion is the second capability. Pacific Elite Term may be converted to eligible Pacific Life cash-value coverage without additional underwriting during the stated conversion period, with an optional Conversion Extension Rider that may extend that period [35]. PL Promise Term converts to PL Promise Conversion UL without new underwriting through the earlier of the guaranteed level-premium period or insured age 70 [37].
Living benefits are the third. Pacific Elite Term materials describe terminal-illness protection and optional disability, chronic-illness, and critical-illness-related benefits, subject to availability, eligibility, restrictions, and limitations [35]. Accelerating benefits reduces the remaining death benefit and may affect public-benefit eligibility or tax treatment.
Build guidelines are the fourth. Google reported that Pacific Life's build charts allow a BMI up to 33 under age 65 and up to 35 at age 65+ to qualify for preferred tiers, which benefits diabetic applicants who carry extra weight [38]. This is a third-party summary of underwriting guidelines, not a Pacific Life-published threshold.
Pricing, Fees, Contracts, and Ongoing Costs
Questions This Section Answers
- How much does Pacific Life cost per month for a Type 2 diabetes applicant, and are there setup or cancellation fees?
- What contract terms and ongoing costs should a Type 2 diabetes buyer confirm before signing with Pacific Life?
No platform could verify an individualized Pacific Life premium for a Type 2 diabetes applicant. Pricing confidence was low across openai, deepseek, grok, and perplexity, and moderate for anthropic and kimi. Premiums depend on age, health class, coverage amount, term length, state, and underwriting outcome [39].
Where numbers exist, they are generic rather than diabetes-specific. Anthropic reported an illustrative standard monthly rate of about $39.92 for a 40-year-old female, super preferred non-tobacco, $1M, 20-year PL Promise Term, with modal factors of 0.51x semi-annual, 0.26x quarterly, and 0.085x monthly against the annual premium [41]. Kimi reported illustrative annual term premiums of roughly $814.85 for a 50-year-old male and $644.91 for a 50-year-old female at Standard Plus Non-Tobacco, rising to about $6,085.46 for a 70-year-old male [42]. These are platform-reported illustrations, not Pacific Life quotes for a diabetic applicant.
On fees, no specific application, policy, diabetes surcharge, or rider fee was publicly identified in the sources reviewed [39]. Optional riders may add charges or reduce policy benefits, and the actual amounts require a quote and policy illustration [43]. Pacific Life states that life insurance is subject to underwriting and approval and that monthly policy charges apply [44].
Contract terms vary. Coverage is subject to underwriting and application approval; product and rider availability varies by state; Pacific Life Insurance Company states it is not licensed to issue insurance products in New York [39]. Sample policy materials describe a free-look cancellation period, but the exact period and terms vary by policy and state [45]. Failure to pay required premiums can cause the policy to lapse or terminate [45]. Term premiums are level during the selected level-premium period and may increase substantially afterward if coverage is renewed [39].
For PL Promise GUL, the buyer must maintain the required premium schedule and no-lapse requirements; the reviewed public materials do not establish diabetes-specific pricing or approval standards for this product [46].
Best Suited For
Questions This Section Answers
- Who is Pacific Life best suited for among Type 2 diabetes life insurance buyers?
- Is Pacific Life a good fit for a Type 2 diabetes applicant diagnosed after age 50 with well-controlled A1C?
Pacific Life is best considered by applicants seeking 10-, 20-, or 30-year term coverage with level premiums during the selected period [48]. It also suits applicants who value the ability to convert term coverage to eligible Pacific Life permanent coverage without new medical underwriting [50].
Platforms most consistently described a favorable scenario for Type 2 diabetes diagnosed after age 50 with A1C under 7.0, no complications, and otherwise strong health metrics [52]. Kimi and google both framed this as the narrow segment where Pacific Life's rates can match the most competitive carriers [53].
Applicants who want a financially strong carrier and can tolerate traditional or accelerated underwriting review are also reasonable candidates [55]. Buyers prioritizing mid-to-high face amounts, roughly $500K–$3M, were described by anthropic as a fit for Pacific Life's pricing bands [57].
Probably Not Best Suited For
Questions This Section Answers
- Who should not choose Pacific Life for life insurance with Type 2 diabetes?
- Is Pacific Life a poor fit for a Type 2 diabetes applicant who needs guaranteed-issue coverage?
Applicants needing guaranteed acceptance or simplified-issue coverage should look elsewhere. Pacific Life's public materials do not clearly describe a simplified-issue or guaranteed-issue life product for diabetes [58].
Applicants whose diabetes is poorly controlled, recently diagnosed, insulin-intensive, or associated with significant complications are not well matched unless Pacific Life confirms an acceptable underwriting class [60]. Anthropic specifically flagged A1C above 8.5 and complications such as nephropathy, neuropathy, or retinopathy as scenarios where other carriers may be more accommodating [61].
Younger applicants diagnosed before age 50 are a weaker fit. Kimi and google both reported that Pacific Life's most favorable rates require diagnosis after age 50, which is more restrictive than Banner Life's reported post-40 threshold [62].
Buyers who need a confirmed quote or acceptance decision before applying, and who do not want to complete medical underwriting, are also poorly matched [64]. Applicants seeking a diabetes-specific wellness program or premium discounts will not find one in Pacific Life's reviewed materials [59].
When Another Option May Be Better
Questions This Section Answers
- What is a better alternative to Pacific Life for a Type 2 diabetes buyer who was diagnosed before age 50?
- When should a Type 2 diabetes buyer choose a guaranteed-issue carrier instead of Pacific Life?
Another carrier may be better in five situations. When the buyer was diagnosed before age 50, Banner Life was repeatedly cited as more aggressive for younger-onset cases [67]. When the buyer needs guaranteed-issue, simplified-issue, or no-exam coverage, Mutual of Omaha was named for that segment [69].
When the buyer has poorly controlled A1C, insulin dependence, or complications, platforms pointed to carriers with more accommodating impaired-risk underwriting, including Prudential and Lincoln Financial for complex cases with medical director review [70]. When the buyer wants a diabetes-specific program with premium discounts tied to healthy behaviors, John Hancock Aspire with Vitality was the only diabetes-specific program identified [69].
When the buyer needs permanent coverage but another insurer provides a clearer guaranteed-premium illustration or more favorable chronic-illness provisions, comparison is warranted [73]. Buyers in New York should also compare, because Pacific Life Insurance Company states it is not licensed to issue insurance products there [74].
Questions to Verify Before Buying
Will Pacific Life provide an informal or preliminary underwriting assessment before a formal application, and will it disclose the likely rating for this buyer's exact A1C, diagnosis age, medications or insulin use, BMI, kidney function, cardiovascular history, and complications [75]?
Will the application require an exam, blood and urine testing, medical records, prescription-history review, or additional attending-physician statements [77]?
What are the exact premiums during the level term, guaranteed renewal premiums afterward, and consequences of changing payment frequency [75]?
For the buyer's state, is Pacific Elite Term or PL Promise Term available, and what are the exact face-amount, issue-age, term, and conversion limits [75]?
What is the precise conversion deadline, are converted rates based on attained age, and is the conversion credit or Conversion Extension Rider available in this state [80]?
Which terminal-, chronic-, critical-illness, disability-, or waiver-of-premium riders are available, what do they cost, and how do benefits reduce the death benefit or affect eligibility for public assistance [80]?
For PL Promise GUL, what premium schedule and no-lapse requirements must be maintained, and what happens after missed or reduced premiums [81]?
What are the free-look, reinstatement, contestability, suicide, renewal, lapse, and cancellation provisions in the actual policy form [83]?
Can an independent agent compare Pacific Life's tentative offer with multiple carriers that actively underwrite Type 2 diabetes before submitting a formal application [75]?
Final AI Consensus Verdict
Pacific Life is a mixed fit for an otherwise stable adult with Type 2 diabetes. Four of seven platforms named it during ranking, at an average listed rank of 5.5 and a best listed rank of 4. Pacific Elite Term is a credible product to investigate because it offers conventional term protection, level-premium periods, conversion flexibility, and optional living-benefit features. PL Promise GUL is more relevant when lifetime coverage is the objective.
The main buyer disadvantage is the absence of publicly verifiable diabetes-specific underwriting and pricing information. Pacific Life should be treated as one candidate for preliminary comparison, not as the established best option. Platform agreement on Pacific Life's general product features does not prove favorable diabetes underwriting or competitive pricing for this condition.
How This Review Was Produced
This review synthesizes fit-research responses from seven AI platforms — anthropic, deepseek, google, grok, kimi, openai, and perplexity — each asked which life insurance carriers are generally worth considering for an adult with Type 2 diabetes in reasonably stable health. Four platforms named Pacific Life during the ranking stage; all seven produced fit findings that are reflected here.
Platform responses were treated as platform-reported evidence, not independently verified facts. Company-owned sources are labeled as owned in the Sources section; independent sources are labeled separately. Where a platform supplied no citation for a factual claim, that claim is labeled platform-reported or unverified.
Methodology Limitations
Platform-reported research dates differ from the authoritative run date of 2026-09-22. Anthropic reported 2026-01-15 and deepseek reported 2026-02-14; the remaining platforms reported 2026-09-22. These dates are provenance metadata and do not independently prove freshness.
The supplied URLs were collected from platform responses and were not independently validated by the writer stage. Citations are platform-reported evidence, not independently verified facts. Deepseek's research ran with search disabled, so its claims require explicit verification before being described as current facts.
Product naming conflicts were not resolved by guessing. Ranking-stage responses referenced Pacific Elite Term, Promise GUL, Promise Term, and Premier Term, while the currently reviewed official term page identifies Pacific Elite Term and PL Promise Term. One official page labels PL Promise Term as California-only while other materials describe broader availability. Buyers should verify current product names and state availability directly.
No public Pacific Life diabetes underwriting guide, A1C threshold, medication rule, complication rule, or diabetes-specific rate table was located. No public evidence establishes that Pacific Life is especially competitive for Type 2 diabetes compared with other insurers. No individualized premium, underwriting class, contract charge, or final rider cost can be verified without a case-specific quote. Platform agreement does not prove product quality.
See the broader Life Insurance for Type 2 Diabetes consensus index for comparisons across qualified options.
Sources
Company-Owned Sources
- PL Promise Term Rate Comparison - July 20, 2026: https://life.pacificlife.com/content/dam/paclife-lid/public/plexpress/products/pl-promise-term/rate-comparison-combo-flyer.pdf
- PL Promise Term - Level Premium Term Life Insurance Product Sheet: https://life.pacificlife.com/content/dam/paclife-lid/public/plexpress/products/pl-promise-term/TMF5078.pdf
- Pacific Accelerated Life+ (PAL+) Underwriting - Three Pathways: https://life.pacificlife.com/content/dam/paclife-lid/public/plexpress/underwriting/underwriting-new-business/PLF4249.pdf
- Pacific Elite Term: https://lifeinsurance.dev-ams.pacificlife.com/home/products/term/elite.html
- Home - Pacific Life: https://plpromise.pacificlife.com/home.html
- Underwriting: https://plpromise.pacificlife.com/home/underwriting.html
- Pacific Elite Term Client Guide: https://www.lifeinsurance.pacificlife.com/content/dam/paclife-lid/public/life-affluent/products/pacific-elite-term/TMC4356.pdf
- Pacific Elite Term - Life Insurance Product: https://www.lifeinsurance.pacificlife.com/home/products/term/elite.html
- PL Promise GUL Client Guide: https://www.pacificlife.com/content/dam/paclife/lid/public/brochures/15-47468-03.pdf
- Sample Policy: Level Premium Term Life Insurance: https://www.pacificlife.com/content/dam/paclife/lid/public/sample-policies/Sample%20Policy%20Term%20P12TRF.pdf
- Pacific Life Financial Strength Ratings: https://www.pacificlife.com/home/about-pacific-life/financial-strength.html
- Financials & Insurance Ratings: https://www.pacificlife.com/home/about/financials-and-insurance-ratings.html
- Pacific Life Individual Life Insurance: https://www.pacificlife.com/home/individuals/life-insurance.html
- Pacific Life Life Insurance FAQs: https://www.pacificlife.com/home/individuals/life-insurance/faqs.html
- Life Insurance Indexed Account Rates - Pacific Life: https://www.pacificlife.com/home/individuals/life-insurance/life-rates.html
- Pacific Life Permanent Life Insurance: https://www.pacificlife.com/home/individuals/life-insurance/permanent-life-insurance.html
- Term Life Insurance: https://www.pacificlife.com/home/individuals/life-insurance/term-life-insurance.html
- Pacific Life Life Insurance Underwriting: https://www.pacificlife.com/home/individuals/life-insurance/underwriting.html
- Official pricing and terms source: https://www.pacificlife.com/home/individuals.html
Additional AI research evidence83 records
- AI research evidence record deepseek:c1
- AI research evidence record deepseek:c4
- AI research evidence record openai:c1
- AI research evidence record deepseek:c6
- AI research evidence record openai:c1
- AI research evidence record openai:c2
- AI research evidence record anthropic:c8
- AI research evidence record anthropic:c4
- AI research evidence record openai:c4
- AI research evidence record perplexity:c5
- AI research evidence record perplexity:c6
- AI research evidence record deepseek:c4
- AI research evidence record openai:c1
- AI research evidence record deepseek:c5
- AI research evidence record anthropic:c1
- AI research evidence record openai:c5
- AI research evidence record deepseek:c6
- AI research evidence record openai:c2
- AI research evidence record anthropic:c4
- AI research evidence record perplexity:c2
- AI research evidence record anthropic:c1
- AI research evidence record perplexity:c4
- AI research evidence record kimi:keypersoninsurance-diabetics
- AI research evidence record google:keyperson_diabetes_rates
- AI research evidence record grok:11
- AI research evidence record anthropic:c7
- AI research evidence record anthropic:c10
- AI research evidence record anthropic:c6
- AI research evidence record anthropic:c3
- AI research evidence record perplexity:c2
- AI research evidence record perplexity:c3
- AI research evidence record openai:c6
- AI research evidence record anthropic:c1
- AI research evidence record grok:14
- AI research evidence record openai:c2
- AI research evidence record openai:c3
- AI research evidence record anthropic:c4
- AI research evidence record google:lovett_financial_sweet_spots
- AI research evidence record openai:c1
- AI research evidence record deepseek:c4
- AI research evidence record anthropic:c4
- AI research evidence record kimi:keypersoninsurance-diabetics
- AI research evidence record openai:c3
- AI research evidence record perplexity:c7
- AI research evidence record openai:c8
- AI research evidence record openai:c4
- AI research evidence record perplexity:c6
- AI research evidence record openai:c1
- AI research evidence record anthropic:c8
- AI research evidence record openai:c2
- AI research evidence record anthropic:c4
- AI research evidence record anthropic:c1
- AI research evidence record kimi:keypersoninsurance-diabetics
- AI research evidence record google:keyperson_diabetes_rates
- AI research evidence record openai:c5
- AI research evidence record deepseek:c6
- AI research evidence record anthropic:c10
- AI research evidence record deepseek:c5
- AI research evidence record kimi:marketwatch-diabetics
- AI research evidence record openai:c1
- AI research evidence record anthropic:c1
- AI research evidence record kimi:keypersoninsurance-diabetics
- AI research evidence record google:keyperson_diabetes_rates
- AI research evidence record deepseek:c4
- AI research evidence record perplexity:c8
- AI research evidence record kimi:moneygeek-diabetics
- AI research evidence record kimi:keypersoninsurance-diabetics
- AI research evidence record google:keyperson_diabetes_rates
- AI research evidence record kimi:marketwatch-diabetics
- AI research evidence record anthropic:c1
- AI research evidence record grok:16
- AI research evidence record kimi:moneygeek-diabetics
- AI research evidence record openai:c4
- AI research evidence record openai:c1
- AI research evidence record openai:c1
- AI research evidence record anthropic:c1
- AI research evidence record openai:c6
- AI research evidence record anthropic:c3
- AI research evidence record anthropic:c4
- AI research evidence record openai:c3
- AI research evidence record openai:c4
- AI research evidence record perplexity:c6
- AI research evidence record openai:c8
Independent Sources
- PL Promise Term Reprice - April 17, 2026 - Targeted Sweet Spot: http://docs.uuinc.com/news/PL%20promise%20term%20reprice%20april17.pdf
- Insurance Topics: Accelerated Underwriting: https://content.naic.org/insurance-topics/accelerated-underwriting
- A Type 2 Diabetes Diagnosis Can Push Life Insurance Premiums Up 25% Per Table Rating: https://dailyinsurance.news/life-insurance-type-2-diabetes-table-rating
- Diabetes, A1C, and CGM Data in Life Insurance Underwriting: https://legalclarity.org/diabetes-a1c-and-cgm-data-in-life-insurance-underwriting/
- Life Insurance With Type 2 Diabetes - Amazing Guide (2026: https://lifeinsureguide.com/life-insurance-with-type-2-diabetes/
- PL Promise Series Underwriting Guide - Diabetes Underwriting: https://lovettfinancial.net/wp-content/uploads/pacific-life-promise-term-underwriting-guide.pdf
- Life Insurance with Type 2 Diabetes: Qualifying for Standard Rates: https://pacificdirectinsurance.com/blog/life-insurance-type-2-diabetes-standard-rates
- Pacific Life Underwriting Guide - Diabetes Requirements: https://pinneyinsurance.com/underwriting-docs/PacLife-Underwriting-Guide.pdf
- Life Insurance for Diabetics - Carrier Comparison and Underwriting Guidelines: https://terminsurancebrokers.com/life-insurance-answers/high-risk-life-insurance/diabetes/
- PL Promise Series of Life Insurance Products - Lovett Financial, Inc: https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQEJ4r5dSEvF1uN_JqZzY8110GV1xTsQJy_WW7ssvkfQ2BG1OjEz32pk9EPNMS4EeBgKtV5Ntl98ueZSsECb29eSnPzKzQAv1TFph4K0P9uciBqi05uh7QqvrUBhZsgfZhksEXKAw8fXmBaz8foPMO_y4Ue1tSRyXZkHdHO5AhT3QfPRvFBWEdAesSQOGv3JgplRwKzh
- How Type 2 Diabetes Impacts Life Insurance Rates and How to Get the Best Policy: https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH6MPbhncXlfZXK0sm8mK7H9RlHdyUE0XVAI9mgZgK6cY_z50i8Zfpu7ksxD584oI4GYrAdWk5QRd_JMAj3JF_kMhroeFphKjsL0T7VIAsCLRg1JPUpharrFZbUIXqV8bCz_hJN-IQqZFzUEyKLnapbFGenJ28=
- Pacific Life (Promise Term) Underwriting Guidelines Explained - Lumis Life: https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQH7PrDxZvQuEPGcdcsONTtnYO6hsgllBHPUTyCupcMTBq1zKAVOmAGSBxIW0cHD2L7pLgWClYv3hZSCS9IqEBpLdRL-Mfa72yNY29ZinqZLqnBw9D2OIrSpiLNlBstiyZSvYZ-Y
- PAL Pre-Qualification Questionnaire: https://www.agencyone.net/wp-content/uploads/2021/06/PAL-Pre-Qualification-Questionnaire.pdf
- Pacific Life Insurance Review – Forbes Advisor: https://www.forbes.com/advisor/life-insurance/pacific-life-insurance-review/
- Compare the Best Life Insurance for People With Diabetes in 2026: https://www.investopedia.com/the-best-life-insurance-for-diabetics-8780621
- How Type 2 Diabetes Impacts Life Insurance Rates and How to Get the Best Policy: https://www.keypersoninsurance.com/life-insurance-for-diabetics/
- 3 Best Life Insurance Companies for Diabetics in 2026: https://www.marketwatch.com/insurance-services/life-insurance/life-insurance-for-diabetics/?eafs_enabled=false
- Best Life Insurance for Diabetics in 2026: https://www.moneygeek.com/insurance/life/best/diabetics/
- Pacific Life Insurance Review 2026 - MoneyGeek: https://www.moneygeek.com/insurance/life/reviews/pacific-life/
- Pacific Life Insurance Review for 2026 (+Options & Prices: https://www.quote.com/companies/pacific-life-insurance-review/
- Pacific Life Insurance Company Review How Their Products, Pricing & Underwriting Compares: https://www.riskquoter.com/company-reviews/pacific-life/
Additional AI research evidence83 records
- AI research evidence record deepseek:c1
- AI research evidence record deepseek:c4
- AI research evidence record openai:c1
- AI research evidence record deepseek:c6
- AI research evidence record openai:c1
- AI research evidence record openai:c2
- AI research evidence record anthropic:c8
- AI research evidence record anthropic:c4
- AI research evidence record openai:c4
- AI research evidence record perplexity:c5
- AI research evidence record perplexity:c6
- AI research evidence record deepseek:c4
- AI research evidence record openai:c1
- AI research evidence record deepseek:c5
- AI research evidence record anthropic:c1
- AI research evidence record openai:c5
- AI research evidence record deepseek:c6
- AI research evidence record openai:c2
- AI research evidence record anthropic:c4
- AI research evidence record perplexity:c2
- AI research evidence record anthropic:c1
- AI research evidence record perplexity:c4
- AI research evidence record kimi:keypersoninsurance-diabetics
- AI research evidence record google:keyperson_diabetes_rates
- AI research evidence record grok:11
- AI research evidence record anthropic:c7
- AI research evidence record anthropic:c10
- AI research evidence record anthropic:c6
- AI research evidence record anthropic:c3
- AI research evidence record perplexity:c2
- AI research evidence record perplexity:c3
- AI research evidence record openai:c6
- AI research evidence record anthropic:c1
- AI research evidence record grok:14
- AI research evidence record openai:c2
- AI research evidence record openai:c3
- AI research evidence record anthropic:c4
- AI research evidence record google:lovett_financial_sweet_spots
- AI research evidence record openai:c1
- AI research evidence record deepseek:c4
- AI research evidence record anthropic:c4
- AI research evidence record kimi:keypersoninsurance-diabetics
- AI research evidence record openai:c3
- AI research evidence record perplexity:c7
- AI research evidence record openai:c8
- AI research evidence record openai:c4
- AI research evidence record perplexity:c6
- AI research evidence record openai:c1
- AI research evidence record anthropic:c8
- AI research evidence record openai:c2
- AI research evidence record anthropic:c4
- AI research evidence record anthropic:c1
- AI research evidence record kimi:keypersoninsurance-diabetics
- AI research evidence record google:keyperson_diabetes_rates
- AI research evidence record openai:c5
- AI research evidence record deepseek:c6
- AI research evidence record anthropic:c10
- AI research evidence record deepseek:c5
- AI research evidence record kimi:marketwatch-diabetics
- AI research evidence record openai:c1
- AI research evidence record anthropic:c1
- AI research evidence record kimi:keypersoninsurance-diabetics
- AI research evidence record google:keyperson_diabetes_rates
- AI research evidence record deepseek:c4
- AI research evidence record perplexity:c8
- AI research evidence record kimi:moneygeek-diabetics
- AI research evidence record kimi:keypersoninsurance-diabetics
- AI research evidence record google:keyperson_diabetes_rates
- AI research evidence record kimi:marketwatch-diabetics
- AI research evidence record anthropic:c1
- AI research evidence record grok:16
- AI research evidence record kimi:moneygeek-diabetics
- AI research evidence record openai:c4
- AI research evidence record openai:c1
- AI research evidence record openai:c1
- AI research evidence record anthropic:c1
- AI research evidence record openai:c6
- AI research evidence record anthropic:c3
- AI research evidence record anthropic:c4
- AI research evidence record openai:c3
- AI research evidence record openai:c4
- AI research evidence record perplexity:c6
- AI research evidence record openai:c8
Verify this research
Check when the research was run, which platforms were included, and what supports the findings.
- Study date
- September 22, 2026
- Platforms analyzed
- 7
- Source records
- 43
- Ranking mentions
- 4 of 7
- Platform share
- 57%
- Final consensus rank
- #5
Behind the findings
Platforms in this study
- ChatGPT
- Claude
- DeepSeek
- Grok
- Perplexity
- Kimi
- Gemini
Source records
23 independent · 20 company-owned
Evidence support
33 direct · 10 partial
Keep in mind
Use the run research_date as the study date. Platform-reported dates are provenance metadata and do not independently prove freshness.
Technical verification details
Use this SHA-256 fingerprint to identify the source snapshot associated with this study.
47a068204c79b7111727074b4efe2d2092ef867b8139fbdcfec3d0ecb7a6e998